Rep. Jefferson Van Drew

Maddy summaryThis bill amends the Affordable Care Act and Medicaid/CHIP programs to deny health insurance subsidies, coverage, and related benefits to individuals with Deferred Action for Childhood Arrivals (DACA) status. Specifically, it excludes people lawfully present only due to the 2012 DHS memo granting deferred action from eligibility for ACA subsidies, Medicaid, and the State Children's Health Insurance Program (CHIP). The bill requires states to remove DACA recipients from enrollment in health plans and rescind any existing waivers that allowed such coverage. It directly affects approximately 800,000 DACA recipients who currently qualify for ACA subsidies and Medicaid/CHIP under existing rules.

Maddy summaryThis bill mandates an interagency review by the Department of Health and Human Services (with Defense and Veterans Affairs) to address lung cancer disparities affecting women. It requires a report evaluating research gaps, improving access to lung cancer screening (especially for underserved groups), and developing public awareness campaigns about early detection. The review will focus on factors like environmental exposures, genomic differences, and treatment responses specific to women, particularly those who never smoked. The report must be submitted to Congress within one year of enactment. This directly affects women at risk of lung cancer, including those with non-smoking-related cases.

Maddy summaryThis bill creates a presumption that minerals from the Democratic Republic of Congo (DRC) containing cobalt and lithium, mined with child or forced labor, cannot be imported into the United States. It requires the U.S. government to develop an enforcement strategy to identify and block such imports, including monitoring supply chains and working with international partners. The bill mandates diplomatic efforts to address child and forced labor in the DRC's mining sector and establishes sanctions against foreign entities that facilitate or engage in such labor practices. The focus is on minerals critical for electric vehicles and electronics, which are heavily sourced from the DRC and processed in China, with specific attention to Chinese mining companies like China Molybdenum that dominate the DRC's cobalt sector.

Maddy summaryThis bill expands Medicare coverage to include home infusion treatment for people with Alpha-1 Antitrypsin Deficiency Disorder, a genetic condition causing lung and liver damage. It specifically covers "augmentation therapy" (a standard treatment using Alpha-1 Proteinase Inhibitor) when administered in a patient's home by qualified providers. Medicare will pay 80% of the cost for intravenous kits and up to 2 hours of nursing care during these home infusions, starting January 1, 2025. The change directly affects Medicare beneficiaries with this condition who require home-based treatment and their qualified home infusion providers.

Maddy summaryThe ARC Act of 2023 establishes a national program to address peripheral artery disease (PAD), which disproportionately affects minority populations and leads to avoidable amputations. The bill requires Medicare and Medicaid to cover PAD screening tests (such as ankle-brachial index testing) for at-risk beneficiaries without cost-sharing, including people 65+ or those with diabetes, smoking history, or other risk factors. It authorizes $6 million annually for a CDC-led education program to inform healthcare providers and the public about PAD prevention and treatment. The bill also creates quality measures to encourage alternative treatments to amputation and establishes a pilot program to test amputation prevention services at healthcare facilities. These provisions aim to reduce amputation rates and improve outcomes for millions of Americans with PAD.

Maddy summaryHR 3851, the Access to Breast Cancer Diagnosis Act of 2023, requires most health insurance plans (including group and individual coverage) to cover diagnostic and supplemental breast exams without any out-of-pocket costs like copays or deductibles. This applies to medically necessary exams used to evaluate abnormalities detected during screening (diagnostic) or to screen high-risk individuals without abnormalities (supplemental), following National Comprehensive Cancer Network guidelines. Plans may still require prior authorization for these exams, and state laws providing stronger protections remain in effect. The law takes effect for plan years beginning January 1, 2024.

Maddy summaryHR 3748, the SAFE Act of 2023, requires U.S. agricultural agencies to proactively negotiate trade agreements with foreign governments to minimize export disruptions caused by animal disease outbreaks. It directs the Secretary of Agriculture, in coordination with the U.S. Trade Representative, to establish regionalization, zoning, or compartmentalization agreements with key export markets for U.S. livestock and animal products. The bill also mandates that the Food Safety and Inspection Service notify state agricultural departments and producer groups within three days if export-related information is removed from official libraries. This directly affects livestock producers and exporters by aiming to stabilize access to international markets during disease events. The law amends the Animal Health Protection Act to formalize these negotiation and notification requirements.

Maddy summaryHR 3674 increases Medicare payments for specific physician services that rely heavily on equipment and supplies (defined as services where 65%+ of costs are for equipment/supplies). It raises payment rates by 10% in 2024 and 15% in 2025 for these services in non-hospital settings like doctor's offices. The bill funds these increases through federal appropriations to the Medicare Trust Fund. It directly affects physicians and clinics providing those defined services, aiming to stabilize reimbursement for providers of high-cost equipment-dependent care.

Maddy summaryHR 3561, the PATIENT Act of 2023, requires hospitals, health insurance plans, and pharmacy benefit managers to publicly disclose detailed pricing information for healthcare services and drugs. Hospitals must publish standard charges for 300+ shoppable services, including gross charges, payer-specific negotiated rates, and discounted cash prices, with updates required annually. Health plans must provide real-time information on in-network rates, cost sharing, deductibles, and prior authorization requirements for covered services. The bill establishes enforcement mechanisms, including civil monetary penalties for non-compliance, with fines ranging from $300 per day for small hospitals to $5 million for large hospitals that fail to comply with the transparency requirements.

Maddy summaryThis bill changes Medicare coverage for colorectal cancer screenings. It eliminates out-of-pocket coinsurance costs for these screenings starting in 2026, requiring Medicare to cover 100% of the cost instead of the previous 85% for that year. The change applies to all subsequent years and directly affects Medicare beneficiaries seeking routine colorectal cancer screenings. The key provision amends Medicare Part B to remove the coinsurance requirement for these specific preventive services.